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~ A  PrOSl~¢tlv~ 1Vial on the Efft~ts of ko~a~n on the 
Oegrtm of Mlt~l Re0urgltatton 
KS, Ogj~rdm. ME_- S~lrplno, J B ~awaf0 M~y~ Chn~: an# Ma)'~ 
FoundatiOn, Rochester, Afm#esot.~. USA 
V~so~lplto~ h~lve ~n ~ ¢limcalty in p~ w~th m~tral fegurgitatmn (MR), 
t~f  e f i~cy  in ~K~ing  volume m,'edoad caused by MR is not quantita, 
l~ely ~nted  In 11 p+ospect~ p~tO! In°l, 29 pts (23 men, age 68 • 14) 
u~n!  a quantttatwe ¢~ngmm at baseline an# tour hours ~fter 
mg ~t lan  o~ally "t~ne regurg~tan! ~ume (RVOl) and effectwe regurgt- 
lant onfK~ (ERe) were qu~nltt~l using two me~ (flow c~rgence  and 
quantitative Doppter) Measuvement~ in~l~ indexed left ventncutar end. 
0kastol~ (EDVI) and ert~systol~; vokm~s (ESVI), ejection fractmn (EF) and 
mean ~ ~sut ,  e (MBP) .  In 24 pts+ the ecP, D( ;a~ram was repeated 
after continued oral k~sartan ft'mral~ 50 mg QD for 30 z 13 days The effects 
ul ~Jsanan are !~uiat~o b~=low 
Ba~el+ne 4 hOurS P' I rnanth P' 
P.~PlmmHgp 101 ~ 11 91 ~ 11 - 00001 93 ; 7 O000r 
ERe tram2) 43 : r? 36 : 16 0 0901 37 : 18 0 0001 
(ccl 75 .~ 29 64 ~ 27 00001 6~ : 29 0 0001 
EOVtlm~'m2) 128 ,. ~ 11~ : r8 - 0000~ 117 t 16 00029 
ESVI !mira2} 48 ~ 2~ 4~ ~ 23 0034 40 20 014 
ConctusK~s. We cortcl~%=d that treatment Of n~lral regurgitation using 
the anc~otens+n II bk~ker to°art°n+ 1) has fa~orab{e ffects wdh a s~gr~fi- 
cam ~educt~on of reg~g~tant volume, mgur~tant entice and felt venb'lcuiar 
rem.JcleSng: 2) these favorable effects appear to persist v~ trine, 3) are ot 
mrYJerate magndu~e, suggeshng that 4) the evaluation of ~ clinical effects 
of the medication m a controlled that ts warranted 
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i Long-term Therapy W'dh Enalapril in Asymptomatic 
Patients W'dh Moderate to Severe Chronic Mitral 
Regurgitation 
AGoda, T Go~a. A. KastratL S O~rko Umvers~ty Ho~tat Cen~e~ Dept at 
Car~. .  T#rana. Albania 
Background: Vaseditators acutely reduce regurg~tant volume and i,"r~ro've 
left ventncuta~ (LV) performance in mdral regurgdation (MR), but mere data 
are necessa W about their long-term efficacy 
Methods: To assess the Iong term effect of ACE inhibition in °symptomatic 
patients (or) ~th  rnodorste 1o severe MR we compared) echocard~ographrc 
left ventncular (LV) pedormance in 30 pt betore and after 6 months After 
randornisation 15 pt were aflocated to enalap.I (E) therapy (24 : 7 rag/day) 
and 15 pt served as control (C). 
Results: There were no d~fferences in baseline Echo measurements ot 
LV diameters, volumes, mass and mean wail stress (MWS) between E and 
C groups. After 6 months pt receiving E had a reduction in end-diastolic 
diameter (EDD) (from 63.9 : 6.7 to 605 ~ 4.1 ram, p = 002) and volume 
(EDVI) (from 115.9 : 21.4 to 102.9 ~ 13.6 mt/rr~, p = 002). LV mass (from 
176.5 ;: 41.0 to 151 4 *. 226 g/n~, p .  0.02) and MWS (from 2530 = 361 
to 223.6 ± 26.8 kdyne/cm ~. p ~ 001). End-systo,c diameter (ESD). volume 
(ESVI) and EF were not altered. In C group EDD. ESD. EDVI. ESVl. El:. 
mass and MWS did not change significantly after 6 months. In addition, there 
was a clear difference between E and C group in EDD (60.5 = 4.1 vs 65.3 : 
7 1 mm, p = 0.03), ESD (37.7 -. 4.1 vs 40.5 +. 4.2 ram, p = 0.07). EDVl (102.9 
13.6vs 1179 *. 28.2ml/m 2 .p -  0.05), mass (1504 : 22.6vs168.3 : 
29.5 g/m z. p - 0.05) and MWS (223.6 : 26.8 vs 257 3 ~. 31 0 kdyne/cm 2. p 
• 0.01) after 6 months. 
Conclusions: Long term therapy with enalapril in asymptomalic pt with 
moderate to severe chronic MR reduces LV size and mass suggesting the 
potential to delay timing f0r mttral valve surgery. 
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Improve Homodynamlcs and Contrlctlle Function in 
Experimental Mitral Regurgitation 
M Ham~wakl, G. 0#Ffeyle, BA  C~lrat~llo. ~ t  ~?y '  of Sou/h 
Carohn~ ~lnd VAMC, Ct~ge~ton, ~l~fh CaroIdna, USA 
Altho,~g~ well established in t110 therapy el ¢o~3gestive t~saR failure, t l~ fete 
0t ACE inhibitor° and beta.bk~kers in milra! regurgitation (MR) reefs+n° 
¢onttover~ttal Accordingly, we ~1~t~11he sequential ~ Of fismop~! (k) 
~ ,~teno(oI (A) (k * A) on 7 dO0° wdh ~evem lett vent~'t~lar (LV) dysftmctmn 
due Io 3 months 0t MR, 
B~e~!i~ 3moMR 6rtl~ MR • L 9 r r~MR*L*A  
LV n",~rs'~OW Ig~g ) 447 ~ 0~5 5fit ~ 0,33 56(}=043 61.3,041' 
RF(%) 600~t5  652141 624~2~ ~4~'41  
PCW (mmHg) 9 f l~13 154~11 1~1~12 (~1~14 = 
K m~e~ 348~ 017 2,51 : 015 ~ 291 ~0t6 33~ ~019 ~ 
"p 005 ~s baseh~e ~p 005 vs .3 me. BW : ~ we+gf~t RF = ~eg,.~g~tant hactmn 
PCW = pulmonary capdtanf wedge pt'eseufe. K = end eyslo+~C stlffr, ess 
We conclude that while there was a tendency for ~mprovemPnt in heine. 
d~/nam~'s w~th L only the cerebra°Iron o! L + A improved hemodynam~ca nd 
normalized contraCtility 
2:45 
~ Eff~-'t= of Inhaled N~!c Oxide in Pa~ts  With 
Severe Mitral Steno,ds and Normal ~ Vmttricular 
Function 
PD. Mahoney, E Lob. LR. Biffs, CW Hanson. H C Hen'mann Unmers~Iy 
ot Pennsylvania Medical Center, Phdadetph~a. Pennsylvama, USA 
M+trat stenos~s is asseoated w~th n~_~rea sod left atrial pressure and pulmonary 
hyperlens~on in the soiling Of nomlal left vonlncular function The hemody- 
nam~c effects ot inhaled nitric 0xl¢~ (NO), a selective pulmonary vasodilator, 
in n~tral steno~s are unknown Nit, le women (mean age 61 ± 7 years) wr~ 
se~.,ere rl~eumat~c n~tral stone°is in'man valve area (MVA) of t .1 ~ 0.2 cm ~ ) 
and normal LV function underwent right and left (vm Irans~eplal approach) 
heart cattteter~at~on: measurerrm.nts were made at baseline, and after tubal- 
mg NO (80 ppm) for 10 minutes (mean _+ SD: " = p ~ 0 05: 
Base,he Nffnc O~l}de 
AO meanimmHg, 96 : tt ~J6 : 13 
LVEDP (mmHg! 15 : 4 15 : 5 
L.A~ mean ~mrnt~g) 26 : 3 27 ~ 5 
PA SVsrQlEImmHgi 62 13 54 : +4" 
CO tF~Ck tm-~) 4 2 : 1 0 4 3 : 12 
SVFI~W~Ui 221 : 70  215  : 68 
PVR |W~ U) 35 ~ 2 6 2 I : I 4" 
In 6 patrents who underwent successful balloon vaNuloplasty, MVA in- 
creased from 1 0 ~ 0 1 to 1 6 -* 0.3 crr~ with a d~ase  in LA pressure 126 
.- 2 to 19 :: 4 mmHg. p ~ 0.05) and PA systolic pressure (55 ± 3 to 44 
7 rnmHg, p < 005)  The CO (4.3 ~ 1 0 ~mtn to 42  I/rain. p =NS) and PVR 
were unchenged (30 WU to 28  WU. p =NS). 
Conclusions 1) NO reduced PVR in patients with mitral slenosrs and 
normal LV funCtion by decreasing PA pressure without altenng LA pressure 
or CO. Thvs differs from previous findings m patients with LV dysfunction rn 
whom NO reduced PVR sorely by increasing pulmonary wL'~ge pressure. 2) 
PVR was unchanged immediately after valvuloplasty, des]0de Eqndence that 
+t ts no( lixed as shown by the vascular reaCtw~ty w~th NO This suggests a 
need for chronic adaptation tO the reduction in LA pressure 
3:00 
~ Diastolic Function in the Progression From Acute to 
' Chronic MR 
P Oagum'. G R Green'. GT  Daughters I1:. NB  Ingels Jr : ,  KL  Yun ~ .
D.C. Miller ~ 'Stanford Unwerstt~ Stanford, CA. USA: :Pale Alto Medrcal 
Foundation. Pale AIto, CA, USA 
Background: The change in LV diastolic function dunng the prOgreSsion from 
acute to chronic MR is unclear. 
Methods: Fifteen dogs unden,'~ent placement of 20 LV myocardial markers 
MR was created by punctunng the postenor leaflet with a Cope biopsy 
needle. Biplane videofluoroscopic studies, performed at 1 week (acute MR) 
and 3 months (chronic MR). were used to assess LV volta'no and wall 
stress. Diastolic funCtion was assessed by the maximum time denvatn/e 
and time constant of iscvolumic Dt~ssu,"e dec~y (r. -dP,'dt). time constant of 
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tsovolunt;~ wall stress d0cay (r,,). early LV filling fraction (EFF), and chamber 
nnd myocardial stiffness constants (K~, K,.) 
Results; Chronic MR increased diastolic fitting volume (FV) by 27% (P 
• 005), Chronic MR dncron~od minimum -dP/dt and increased both r and 
r,, No statistically sigl~ilicant differences wore obson/od in K, or K.~ (Table), 
[moan :t; SD; 'P ~; 0.05; ~lp = N,S, by t tnst], 
(;ctP/dt' ImmHFI P) ~ " (m~) 'r~ (re,q) ~FF '  K[, ~l Km ~ 
Act~lo 15t~ 303 3~I 0,5~ 0,00 2~,~ 
MR ~27a ~4 ~ t4,7 10,~1 t044 t17~ 
Chromg 1.12,1 ,IF) Q 456 0,74 qO~ 22.5 
MR taO~ 1~13 ~7,0 ~0~ t0,~6 I t57 
C_onclu~inn: Diastolic hlnction ~B mtpnirod in tits progrossi{~n from acute 
to chronic MR witi~o~¢t cl {'mgas in myocardial or chamber ~tiffness p=upnrtioa 
in tht~ oantno model o1 MR, Dlastnlte dysfunction (n chronic MR i~ associated 
with changes in LV tilling pnft~rn a~ nvidencod by tl~o increase in EFF, 
3;15 
~-8~ Importnn¢~ of Mltrnt Annular Performnn~. I,, 
Determining the Me©h~nl#m of Fun¢~tlonal Mltral 
Regurgitation 
A,U, Chni, C,A Reldnn, MH Crawlo~ Univem#y et New Mexico HSC anal 
Aft~=~quer~lm VAMC, AIb,gue~lue NM, M~i¢~ 
The mechanism el luect~enal m~t(~l iogulgllall0n (MR) It~ not well dehned 
Both an in~re~o in ~nnul~t diameter and changes in mitral valve appara- 
tus 0oomoltV a,~ a re,lilt Of chooses in LV sh[tpn h~ve hoes Implicated in 
the past, Dobulamlna stimulation would ba nxpocfod to change LV 8y~,lolic 
function and mllrel valve geomoln/, therefore, compnnng the LV shape, and 
mttrat ann[liar dtamater nt rest and peak dobutamino do,~o would aid in un- 
de~mtandlng the machl~nl~m of functional MR, We studied 1~ male patients 
without significant angiographic comnnrl aden/disease with ~f lens! rmld 
functional MR, Standard TEE viaw~ wore obtained at rest and peak dobu- 
famine Infusion (25 ~ g ug/kgtmtn). Oobutamino decreased LV end systolic 
votuma (LVESV) from 130 ~ 55 ml to 103 ~ 45 ml (p.  0,01) and incloasod 
the LV election fraction (EF) from 20 t 10% to 31 t 12% (p - 0,01) nnd 
signilicQntly decreased the MR Jot area from 3.1 ~ 1,6 cm:' 1o I 0 ~ t '5 era" 
(p - 0,001), How(~ver, the changes in LVESV and EF did not correlate with 
the mdtlCtion tn MR seventy (r ~ 0,39 and 0,28, respectively), Dobutamlno 
also ,qlgnlficontly decreased the mitral annular diameter in systole (3.9 ~ 0,3 
emlu3.6 = 0.3cn',p. 00tleqdmJiastotot4.1 t 03crate38  t 0,3era. 
p - 0,02), Mitral nnnutar sho~loninq and shodening haclion also improved 
witl~ dobutamino nnd correlated we~l with changes in MR seventy (r = QS0. p 
• Out and r = 079, p. 001) We conc}udo that lunclienal mitral regurgita- 
tion appoam to bo more closely related to changes in annular d~amotor and 
contractile state than changes in LV systolic shapo or function Therefore, 
in patients with s~gnd~cant functional MR, tho[apoubc attempts at altering LV 
size or function may be loss effective than changing the size el the mitral 
annulus with an annuloptasty 
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~ Development and Progression of Transplant 
Vassulopathy: Serial Intravaseular Ultrasound Study 
SR Kapadia, KM Ziada, T,D, Crowo, JB. Young, R.C Starling, 
M.J. Silver, S,E, Ntssen, E,M, Tuzcu. The Cleveland Chnic Foundahon. 
Cleveland, Ohio, USA 
B~..%~ound. Although transplant vaseulopathy ~s a rosier factor limiting out- 
come alter cardiac transplantation, now lesion formation and disease pro- 
gression over time have not been thoroughly doscnbed. 
Method Serial ultrasound was performed 4 weeks. 1 year and 2 years 
alter transplantation (mean 28 ~ 17, 370 ~ 31. and 761 ~ 49 days, respec- 
tively) At a series el matched sites, maximum intimat hickness (Pmax) and 
intimal area were measured at all three time points. Intimat are:~ was defined 
as the difference beD, veen external elastic lamina and lumen areas. A new 
transplant vasculopathy lesion was defined as Pmax -0.5 mm on follow-up 
examination at a previously normal sde. The availability of 4 week ultrasound 
measurements enabled exclusion of sites containing donor-transmitted ath- 
erosclerosis. 
Results: A total of 289 sites in 50 patients were analyzed at all three tirne 
points At one year, 54 sites in 22 patients showed new lesions with Pmax and 
intimsl area averaging 0,76 ~ 0,19 mm and 5.60 ~- 1,92 mm ;~, respectively 
At two year follow-up, those same sites showed minimal, if any, progression 
with Pmax and intimal area averaging 0,78 t 0.26 mm and 6,14 t 2,29 
mm ~, rospoctlvoty, p = NS, However, completely now Iosluns developed ot 
52 ~itos In 28 patients at two year examination. Of the 26 patients with new 
disease at two years, 14 did not have any trnn~plant vasculopathy lesions at 
one year, The severity of late developing lesions was similar to lesions that 
developed within the fimt year, Pmnx and intimal aro~ averaged 0,77 ± 0,36 
mm and 4.83 ~ 2,54 mm% p.  NS compared to the flint year lesions, 
Conclusion: Trnnsplant vnBculop~thy I~ ~ pro4ms~ charaotonz.~l by con- 
tinuou~ and relatively constant d~volopmont of now lesions at prov~ously 
uninvolved sites during the first two year~, Typic~ally, progression el el{isling 
lesions is very slow with barely do.toctable changB~ b~two~a the first and 
second years, Thus, therapy targeted at preventing new !eston foffnalion 
may signili~anfly improve outcome. 
2:15 
D, .o . . . . .o ,e . .e . . . . .o . . .o ,oo ,o  end Funct!onal 
Changes In Ca~!lac Allogralt Vasc~U!ormth¥, . . 
Asaeasment by Serial Intra~omnary U!trasouna ano 
Doppler Stud!n 
V. KlatlSl~, C Spas, K .H  Honneko, J Rieber, A. K01 ~t, H $inzker, 
E Regar, F, Warner, J. Matt, C Weber, P. Uboduhw ~ , K Tholsen 
B Roicl~ad q Haf:;lfd Mud~. Opt at Card~olog~ Khnikum Innensta~, 
Oerm~ln),; ~ Opt at Card~ac Surgoly Univemtty at Afumch. Oerrt~ny 
Etackpround Intracoron,m/ ultlasound (IVUS) has the poteotrs| to assess 
the pregression el intire~l pro!iteration in transplant colonary adory d,sease 
(TxCAD). The functional significance of TxCAD can be determined invasively 
by measurement of coronary flow roseate (CFRL We sought te evaluate 
whether a progression of TxCAO is paralleled by an =mpairmom ut CFR by 
means of sonal IVUS nnd Doppler studios. 
Methods Two groups (Gr.) of patients (P) were studiud sequeebally: Gr 
I |30 P) immediately (% 3 months) and 12 months after heart tronsptamation 
(Ht~). Gr, II (26 P) late ( .  12 months, mean t9 ; 26) after Htx and 12 months 
themaltor Baseline sod hyporomic oronary ftow m,,eroge peak velocity were 
measured to calculate CFR (16 i~g adenosine. 0.014 in. Doppler guide w~re) 
IVUS was podormod to determine the moan plaque index (PI = [vessel 
area lumen areal . 100Nessel area) of the vessel studied wah Dapple., 
Tire use at a motorized IVUS pult-lm'~ck system m all 92 studies allowed the 
=dentdicahon at corresponding sites between baseline (easeL) and follow-up 
(F-up) study. 
Results, 
Pi l",-) \PI i-.,) CFR \CFR 
~seL  F up  Basel F-~;: 
(~ I 7 10 1T ~ 12" 10 : 10 2G ~ 07 34 t 09" 08 ~ OS 
~it II lt~ ~ 13 22 13 = 5 : I1 34 O~ 35 : 09 01 : O? 
t' :P  0001 = =P 002 F-upvs ~lseL) 
Conclusion: DeSpite a marked progress[on of TxCAO m the first year 
after transplantation, an improvement of CFR to high natural values was 
obsowed. Late alter Htx. CFR remained unchanged, although intimal hyper- 
ptasia ludher increased. Thus, endothelial independent CRF is not a reliable 
functional parameter to assess the progression of TxCAD tn the hrsl year 
and late after Htx. 
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- - - -  F853- 1 u,t.aso.nd Ev,denoe o, Compa.ab,  . s,on Se.r, . 
at Proximal and Distal Sites in Transplant Coronary 
Disease 
S.R Kapadia, EM, Tuzcu, TD Crowe, K M. Zinda. J.e. Young. 
C, Bott-Sitverman. C Nanns, SE Nissen The Cleveland Chmc Foundation 
Cleveland. Ohio. USA 
Background. Necropsy studies of transplant coronan/disease suggest more 
severe disease occurs in distal vessels, but post-modem examination rarely 
encounters patients soon alter transplantation. 
Methods: Intravascutar ultrasound was performed in 93 patients. 1 month 
and 1 year after trahsPlanlation (mean 27 t 15 and 370 : 24 days). Artenes 
were dwided into proximal and distal segments using the Coronapj Aden/ 
Surgen/Study (CASS) classification, Matched sites at baseline and fellow-up 
examinations were analyzed for maximal intimal thickness (Pmax). A lesion 
(Pmax ~0.5 ram) present at baseline was defined as a donor lesion and a 
lesion identified on follow-up at a previously normal site was defined as a de 
nova lesion. 
Results: Of 617 sites studied at 1 year. 89 had donor and 107 had de nova 
lesions. Pmax for both donor and de nova lesions was similar in proximal 
